FT.com / Search

1-10 of 10,244 results for Jacquelin Davis v. O'Melveny & Myers LLP

Sorry, we found no matches with all of your words. Here are the nearest matches with some of the words.

FT Suggests - Try these pages on FT.com

Sort by:

Relevance
Date

February 1, 2010
BSkyB v EDS: Why is the case so important?
The case of EDS v BSkyB is by far and away the most important legal case in the IT area for a decade. Not since the 1996 case of St Albans City and District Council v International Computers Limited (which defined whether software was goods... By Dai Davis, IT lawyer and partner at Brooke North LLP
2:00am
Looming commercial real estate crisis offer 'bonanza'
...said: "We've come off the precipice and moved back into more healthy territory."Credit markets had come back sharply in a V-shaped recovery, he said. "It was the best period for buying distressed debt we have seen . . . 18 months ago we were backing... By Martin Arnold in Berlin
September 23, 2008
Bristol-Myers raises stakes in bid for ImClone
Bristol-Myers Squibb incr eased the pressure on ImClone...ImClone’s shareholders. Bristol-Myers, a longstanding partner of ImClone that...with five nominees proposed by Bristol-Myers. Bristol-Myers made a $60-a-share... By Julie MacIntosh in New York
August 4, 2008
Imclone says $4.5bn Bristol-Myers bid too low
...Imclone’s board on Monday said Bristol-Myers Squibb’s $60-per-share takeover...also questioned the role of a Bristol-Myers designee on the Imclone board. Imclone said it was reviewing whether Bristol-Myers might have gained access to “confidential... By Daniel Pimlott in New York
July 31, 2008
Bristol-Myers in $4.5bn Imclone offer
Bristol-Myers Squibb offered on Thursday to buy the 83...closing share price on Wednesday. Bristol-Myers is already ImClone’s largest shareholder...cancer drug, since 2001, when Bristol-Myers agreed to pay $1bn, or $70 a share, for... By Julie MacIntosh and Daniel Pimlott in New York
July 31, 2008
Bristol Myers/Imclone
...beef up that revenue stream. Bristol-Myers Squibb on Thursday became the latest big...activist investor Carl Icahn. Bristol-Myers already owns 17 per cent of ImClone and...5bn for the remaining shares. Bristol-Myers says the offer is part of its “string of pearls...
March 16, 2008
Bristol-Myers sounds out baby food sale
Bristol-Myers Squibb is quietly sounding out potential bidders for a possible sale of Mead Johnson, its baby formula business, which is valued... By Lina Saigol in London and Christopher Bowe in New York
4:36pm
Apollo predicts ‘bonanza’ in commercial property
...ve come off the precipice and moved back into more healthy territory.” He said credit markets had come back sharply in a V-shaped recovery. “It was the best period for buying distressed debt we have seen, perhaps in our careers... 18 months... By Martin Arnold in Berlin
February 9, 2010
Xstrata dividend makes a comeback - but only just
There are few broader-shouldered executives than Mick Davis of Xstrata. But it would be unfair to lay the responsibility...shareholders, who are looking for something different from Mr Davis. He did remark laconically at yesterday's London presentation... By Andrew Hill, Ben McLannahan and Paul Betts
February 8, 2010
Xstrata dividend makes a comeback – but only just
There are few broader-shouldered executives than Mick Davis of Xstrata. But it would be unfair to lay the responsibility...shareholders, who are looking for something different from Mr Davis. He did remark laconically at yesterday’s London presentation... By Ben McLannahan in Hong Kong